Next Article in Journal
Improved Enantioselectivity for Atenolol Employing Pivot Based Molecular Imprinting
Next Article in Special Issue
Oxadiazole/Pyridine-Based Ligands: A Structural Tuning for Enhancing G-Quadruplex Binding
Previous Article in Journal
3D-Conformer of Tris[60]fullerenylated cis-Tris(diphenylamino-fluorene) as Photoswitchable Charge-Polarizer on GHz-Responsive Trilayered Core-Shell Dielectric Nanoparticles
Previous Article in Special Issue
Linking Temperature, Cation Concentration and Water Activity for the B to Z Conformational Transition in DNA
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessArticle
Molecules 2018, 23(8), 1874;

A Fragment-Based Approach for the Development of G-Quadruplex Ligands: Role of the Amidoxime Moiety

Department of Molecular Medicine, University of Padua, via A. Gabelli 63, 35121 Padua, Italy
Department of Chemistry, University of Pavia, Viale Taramelli 10, 27100 Pavia, Italy
Authors to whom correspondence should be addressed.
Academic Editor: Ramon Eritja
Received: 2 July 2018 / Revised: 23 July 2018 / Accepted: 24 July 2018 / Published: 27 July 2018
(This article belongs to the Collection New Frontiers in Nucleic Acid Chemistry)
Full-Text   |   PDF [2275 KB, uploaded 27 July 2018]   |  


G-quadruplex (G4) nucleic acid structures have been reported to be involved in several human pathologies, including cancer, neurodegenerative disorders and infectious diseases; however, G4 targeting compounds still need implementation in terms of drug-like properties and selectivity in order to reach the clinical use. So far, G4 ligands have been mainly identified through high-throughput screening methods or design of molecules with pre-set features. Here, we describe the development of new heterocyclic ligands through a fragment-based drug discovery (FBDD) approach. The ligands were designed against the major G4 present in the long terminal repeat (LTR) promoter region of the human immunodeficiency virus-1 (HIV-1), the stabilization of which has been shown to suppress viral gene expression and replication. Our method is based on the generation of molecular fragment small libraries, screened against the target to further elaborate them into lead compounds. We screened 150 small molecules, composed by structurally and chemically different fragments, selected from commercially available and in-house compounds; synthetic elaboration yielded several G4 ligands and two final G4 binders, both embedding an amidoxime moiety; one of these two compounds showed preferential binding for the HIV-1 LTR G4. This work presents the discovery of a novel potential pharmacophore and highlights the possibility to apply a fragment-based approach to develop G4 ligands with unexpected chemical features. View Full-Text
Keywords: G-quadruplex; amidoximes/oxadiazole/pyridine; fragments; FBA; FRET-melting G-quadruplex; amidoximes/oxadiazole/pyridine; fragments; FBA; FRET-melting

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Tassinari, M.; Lena, A.; Butovskaya, E.; Pirota, V.; Nadai, M.; Freccero, M.; Doria, F.; Richter, S.N. A Fragment-Based Approach for the Development of G-Quadruplex Ligands: Role of the Amidoxime Moiety. Molecules 2018, 23, 1874.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top